Lysine clonixinate
featured

We are open as normal in holiday season. We are closed in Dec 24, Dec 25 and Jan 1.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596478

CAS#: 55837-30-4

Description: Lysine clonixinate is a non-morphinic analgesic.


Price and Availability

Size Price Shipping out time Quantity
2g USD 380 2 Weeks
5g USD 720 2 Weeks
10g USD 1250 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-12-05. Prices are subject to change without notice.

Lysine clonixinate purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 596478
Name: Lysine clonixinate
CAS#: 55837-30-4
Chemical Formula: C19H25ClN4O4
Exact Mass:
Molecular Weight: 408.88
Elemental Analysis: C, 55.81; H, 6.16; Cl, 8.67; N, 13.70; O, 15.65


Synonym: Lysine clonixinate; Dolalgial; Clonixin lysine salt; L-104; L 104; L104;

IUPAC/Chemical Name: L-lysine compound with 2-((3-chloro-2-methylphenyl)amino)nicotinic acid (1:1)

InChi Key: CVNFYQCHAWFYQI-ZSCHJXSPSA-N

InChi Code: InChI=1S/C13H11ClN2O2.C6H14N2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12;7-4-2-1-3-5(8)6(9)10/h2-7H,1H3,(H,15,16)(H,17,18);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1

SMILES Code: N[C@@H](CCCCN)C(O)=O.O=C(C1=CC=CN=C1NC2=CC=CC(Cl)=C2C)O


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Pineros I, Slowing K, Serrano DR, de Pablo E, Ballesteros MP. Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation. Eur J Pharm Sci. 2017 Apr 1;101:220-227. doi: 10.1016/j.ejps.2016.12.030. Epub 2016 Dec 29. PubMed PMID: 28042099.

2: Orr SL, Aubé M, Becker WJ, Davenport WJ, Dilli E, Dodick D, Giammarco R, Gladstone J, Leroux E, Pim H, Dickinson G, Christie SN. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015 Mar;35(3):271-84. doi: 10.1177/0333102414535997. Epub 2014 May 29. Review. PubMed PMID: 24875925.

3: Velásquez GC, Santa Cruz LA, Espinoza MA. Ketoprofen is more effective than diclofenac after oral surgery when used as a preemptive analgesic: a pilot study. J Oral Facial Pain Headache. 2014 Spring;28(2):153-8. doi: 10.11607/ofph.1200. PubMed PMID: 24822238.

4: Perez-Urizar J, Martínez-Rider R, Torres-Roque I, Garrocho-Rangel A, Pozos-Guillen A. Analgesic efficacy of lysine clonixinate plus tramadol versus tramadol in multiple doses following impacted third molar surgery. Int J Oral Maxillofac Surg. 2014 Mar;43(3):348-54. doi: 10.1016/j.ijom.2013.08.003. Epub 2013 Sep 14. PubMed PMID: 24042066.

5: Ortiz ME, Bühler MI, Zelarayán LI. Involvement of PLA2, COX and LOX in Rhinella arenarum oocyte maturation. Zygote. 2014 Nov;22(4):440-5. doi: 10.1017/S096719941200069X. Epub 2013 Feb 27. PubMed PMID: 23443017.

6: Marcelín-Jiménez G, Angeles AC, García A, Morales M, Rivera L, Martín-Del-Campo A. Bioequivalence of 250 mg lysine clonixinate tablets after a single oral dose in a healthy female Mexican population under fasting conditions. Int J Clin Pharmacol Ther. 2010 May;48(5):349-54. PubMed PMID: 20420792.

7: Noronha VR, Gurgel GD, Alves LC, Noman-Ferreira LC, Mendonça LL, Aguiar EG, Abdo EN. Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2009 Aug 1;14(8):e411-5. PubMed PMID: 19415056.

8: Krymchantowski AV, Carneiro H, Barbosa J, Jevoux C. Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: a single-blind, randomized study. Arq Neuropsiquiatr. 2008 Jun;66(2A):216-20. PubMed PMID: 18545786.

9: Franchi AM, Di Girolamo G, De los Santos AR, Marti ML, Gimeno MA. Ex vivo effects of lysine clonixinate on cyclooxygenases in rat lung and stomach preparations. Inflammopharmacology. 1999;7(4):401-11. PubMed PMID: 17657442.

10: Krymchantowski AV, Peixoto P, Higashi R, Silva A Jr, Schutz V. Lysine clonixinate vs naproxen sodium for the acute treatment of migraine: a double-blind, randomized, crossover study. MedGenMed. 2005 Dec 14;7(4):69. PubMed PMID: 16614691; PubMed Central PMCID: PMC1681714.

11: Krymchantowski AV, Silva MT. Intravenous lysine clonixinate for the acute treatment of severe migraine attacks: a double-blind, randomized, placebo-controlled study. Curr Ther Res Clin Exp. 2003 Sep;64(8):505-13. doi: 10.1016/j.curtheres.2003.08.008. PubMed PMID: 24944400; PubMed Central PMCID: PMC4053037.

12: Di Girolamo G, Farina M, Riberio ML, Ogando D, Aisemberg J, de los Santos AR, Martí ML, Franchi AM. Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum. Br J Pharmacol. 2003 Jul;139(6):1164-70. Erratum in: Br J Pharmacol. 2004 Apr;141(7):1234. PubMed PMID: 12871835; PubMed Central PMCID: PMC1573931.

13: Lee JM, Park KM, Lim SJ, Lee MK, Kim CK. Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction. J Pharm Pharmacol. 2002 Jan;54(1):43-9. PubMed PMID: 11829128.

14: Pineros I, Ballesteros P, Lastres JL. Extraction and LC determination of lysine clonixinate salt in water/oil microemulsions. J Pharm Biomed Anal. 2002 Feb 1;27(5):747-54. PubMed PMID: 11814716.

15: Russmann S, Dilger K, Trenk D, Nagyivanyi P, Jähnchen E. Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon. Arzneimittelforschung. 2001 Nov;51(11):891-5. PubMed PMID: 11765590.

16: Di Girolamo G, Franchi A, De Los Santos AR, Martí ML, Farina M, Fernández de Gimeno MA. [Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia]. Medicina (B Aires). 2001;61(5 Pt 1):566-72. Spanish. PubMed PMID: 11721323.

17: de los Santos AR, Zmijanovich R, Pérez Macri S, Martí ML, Di Girolamo G. Antispasmodic/analgesic associations in primary dysmenorrhea double-blind crossover placebo-controlled clinical trial. Int J Clin Pharmacol Res. 2001;21(1):21-9. PubMed PMID: 11708572.

18: Errasti AE, Rey-Ares V, Daray FM, Rogines-Velo MP, Sardi SP, Paz C, Podestá EJ, Rothlin RP. Human umbilical vein: involvement of cyclooxygenase-2 pathway in bradykinin B1 receptor-sensitized responses. Naunyn Schmiedebergs Arch Pharmacol. 2001 Aug;364(2):149-56. PubMed PMID: 11534854.

19: Kramer EH, Sassetti B, Kaminker AJ, De Los Santos AR, Martí ML, Di Girolamo G. [Effects of lysine clonixinate on platelet function. Comparison with other non-steroidal anti-inflammatory agents]. Medicina (B Aires). 2001;61(3):301-7. Spanish. PubMed PMID: 11474878.

20: Krymchantowski AV, Barbosa JS, Cheim C, Alves LA. Oral lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled study. Arq Neuropsiquiatr. 2001 Mar;59(1):46-9. PubMed PMID: 11299430.